Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
about
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral loadDiagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseCombined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B.Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Non-invasive diagnosis of hepatitis B virus-related cirrhosisLiver elastography, comments on EFSUMB elastography guidelines 2013.Evolving therapies for liver fibrosis.Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.Meta-analyses of FibroTest diagnostic value in chronic liver disease.Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis BEvaluation of the patient with hepatitis BLiver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study.Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.Liver biopsy for histological assessment: The case against.Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B.Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.Emerging drugs for hepatitis B.Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.FibroMAX: towards a new universal biomarker of liver disease?Why, who and how should perform liver biopsy in chronic liver diseases.Assessing liver fibrosis.End points of therapy in chronic hepatitis B.Hepatitis B: are non-invasive markers of liver fibrosis reliable?Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.Non-invasive assessment of liver fibrosis.Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B.Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
P2860
Q21144283-C52A0BAF-8E0C-4407-A333-4B7D0B8A56C6Q27496667-07D01128-789E-4701-9BE4-327A0F95B36FQ30383654-F1A61EED-199A-4C95-A3A7-BC5AD97473B6Q30397191-8A615DB2-F523-47B9-A4A2-6CAF60C6B06EQ30430774-52EFAE56-0001-462F-90EC-2FEFFB37A74BQ30442641-F98FD3F7-B874-4D2A-837A-D56D28C6DB2FQ30448132-40CD23CB-617E-43E8-AFE7-143482CDEF49Q30539166-5DCF3176-8725-4BF0-907F-55834379B364Q33263279-A9FB50D1-676E-479F-B3F9-168156F4F384Q33302708-FE7DE315-7D68-4369-882E-069571E2CDFCQ33787916-F10736B7-481C-429F-AE76-9DD9BCBB06C3Q33896660-8C5603AF-8335-47D4-9B06-3E1B1C291CD9Q34200861-A2F5DE47-E99C-426E-9DBC-7B6C021F8C4EQ34303163-B414EE9C-EA2D-46D4-8C7A-DE1DC54B5D11Q34469006-954C121E-9F46-489C-AB83-EB45326FE9D8Q34500227-E0788501-A9EF-4A70-AE34-F7FB4054F172Q34851047-126D1D74-3033-4E77-8E13-C4FCC90A943AQ34892910-CC79F267-C1A2-408F-B29F-975989B45C3AQ35359369-7FEDB5B9-44B9-4B92-9838-E220A86A2CA5Q35908687-57FD3DA5-FBD0-410D-850A-6D43CB13C120Q36445386-BEB2C77B-2143-4D1A-9AAB-41BD6DB627D6Q36950410-8EF4AEEC-DDAA-44B4-9F91-450978214C99Q37182969-3355A07A-E8BD-4374-84BD-F25CE16F7B60Q37345958-C9D8B066-7747-4AB2-85B5-E8D4852293B5Q37688129-9BB296FF-3C4E-419C-B9DA-4808CB91CD82Q38174256-A4506A5A-78E0-4D7F-B799-5CE2BCC44324Q38303313-ECCCF9D2-2178-4980-9680-A3C4204DC2B5Q40707349-C7FE1ECA-CED4-4E80-9727-8B4225AA9CD0Q42406716-BDAB08CA-777F-4D0F-80BC-CE5439A0798CQ44439148-0EE5B061-9B5A-4655-A0DF-0873BE2BAB94Q44590666-7E0A44CA-B9E9-466D-9013-4A444988D3C9Q46675147-8443BFF0-2AF9-4F54-A868-32C7B9DE014EQ51562701-0E419DC7-A694-448E-9BEE-2486D77A9189Q51666681-F7821558-5D39-4071-AD54-1C3259B1ECCAQ51915037-F7DF2E2B-0351-4681-9430-D7B830BA5D0B
P2860
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Longitudinal assessment of his ...... chronic hepatitis B infection.
@en
Longitudinal assessment of histology surrogate markers
@nl
type
label
Longitudinal assessment of his ...... chronic hepatitis B infection.
@en
Longitudinal assessment of histology surrogate markers
@nl
prefLabel
Longitudinal assessment of his ...... chronic hepatitis B infection.
@en
Longitudinal assessment of histology surrogate markers
@nl
P2093
P2860
P50
P1476
Longitudinal assessment of his ...... chronic hepatitis B infection
@en
P2093
Abdelkader El Hasnaoui
Alain Slama
Christian Trepo
Francoise Imbert-Bismut
Françoise Degos
Mona Munteanu
Parviz Parvaz
Paul Landais
Vincent Thibault
P2860
P304
P356
10.1111/J.1572-0241.2005.41957.X
P407
P577
2005-09-01T00:00:00Z